Evidence map›Paper›PMID 42019812›Full record

ArticleJournal of molecular biology2026

Serum-antibody Profiling of H3N2-infected Ferrets Using a Combinatorial Phage-display Random Peptide Library.

Tehila Yehudai, Gaik Tamazian, Lakshminarasaiah Uppalapati, Sandra Völs, Saranya Sridhar, Guadalupe Cortés, Thorsten U Vogel, Anna Roitburd-Berman, Jonathan M Gershoni

Abstract read
In one paragraph

Article in Journal of molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tehila YehudaiThe Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Gaik TamazianThe Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Lakshminarasaiah UppalapatiThe Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Sandra VölsComputational Discovery, Compugen Ltd., Israel.
Saranya SridharSanofi Vaccines R&D, London, UK.
Guadalupe CortésSanofi Vaccines R&D, Cambridge, MA, USA.
Thorsten U VogelSanofi Vaccines R&D, Cambridge, MA, USA.
Anna Roitburd-BermanThe Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Jonathan M GershoniThe Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel. Electronic address: gershoni@tauex.tau.ac.il.

Funding

Bill & Melinda Gates Foundation INV-004951Gates Foundation INV-004951
6 · The paper itself

Abstract

The repertoire of antibodies in serum, known as the "IgOme", is highly diverse and unique to each individual as it reflects the cumulative history of personal encounters with pathogens. Consequently, profiling this repertoire may serve as a diagnostic tool for human viral infections. To explore this potential, we previously developed a computational pipeline called Motifier. The pipeline relies on random peptide sequences affinity-selected by monoclonal antibodies, demonstrating that the specifically amplified peptides can act as markers for the antibodies they bind. In this study, we evaluated whether Motifier is applicable to highly complex biological samples such as serum, which contain vast collections of antibodies, and whether biological conditions can be identified through serum-profiling. As a model system, we analyzed sera from ferrets infected with H3N2 influenza A strains. Our analyses revealed two principal findings: (i) each ferret displayed a strong and distinct antibody signature, highlighting the dominance of baseline "personal" repertoires; and (ii) peptide-motif markers associated with infection could be identified. Using these infection-related markers, we built a Random Forest classifier, which demonstrated that the markers not only characterized the biological condition but also enabled accurate prediction of unseen samples.

Indexed as

Antibodies, ViralFerretsInfluenza A Virus, H3N2 SubtypeOrthomyxoviridae InfectionsPeptide LibraryAnimalsAntibodies, MonoclonalAntibodies, MonoclonalAntibodies, ViralPeptide LibraryDeep-Panninghigh-throughput sequencingIgOmemachine learningphage display

Identifiers

PMID42019812
PMCPMC13348039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.